During stages @ and @ , mean ALSFRS-R declined more slowly in participants who received @ g ceftriaxone than in those on placebo ( difference @ units per month , @ % CI @ to @ ; p = @ ) , but in stage @ functional decline between the treatment groups did not differ ( @ , -@ to @ ; p = @ ) .